Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study
- PMID: 17389308
- PMCID: PMC2758770
- DOI: 10.1212/01.wnl.0000257815.20548.df
Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study
Abstract
Background: Systemic inflammation is associated with ischemia and Alzheimer disease (AD). We hypothesized that inflammatory biomarkers would be associated with neuroimaging markers of ischemia (i.e., white matter hyperintensities [WMH]) and AD (i.e., total brain volume [TCB]).
Methods: MRI WMH and TCB were quantified on 1,926 Framingham Offspring participants free from clinical stroke, TIA, or dementia (mean age 60 +/- 9 years; range 35 to 85 years; 54% women) who underwent measurement of a circulating inflammatory marker panel, including CD40 ligand, C-reactive protein, interleukin-6 (IL-6), soluble intracellular adhesion molecule-1, monocyte chemoattractant protein-1, myeloperoxidase, osteoprotegerin (OPG), P-selectin, tumor necrosis factor-alpha (TNFalpha), and tumor necrosis factor receptor II. To account for head size, both TCB (TCBV) and WMH (WMH/TCV) were divided by total cranial volume. We used multivariable linear regression to relate 10 log-transformed inflammatory biomarkers to brain MRI measures.
Results: In multivariable models, inflammatory markers as a group were associated with TCBV (p < 0.0001) but not WMH/TCV (p = 0.28). In stepwise models adjusted for clinical covariates with backwards elimination of markers, IL-6 and OPG were inversely associated with TCBV; TNFalpha was inversely related to TCBV in a subset of 1,430 participants. Findings were similar in analyses excluding individuals with prevalent cardiovascular disease. The relations between TCBV and inflammatory markers were modified by both sex and age, and generally were more pronounced in men and in older individuals.
Conclusions: Although our observational cross-sectional data cannot establish causality, they are consistent with the hypothesis that higher inflammatory markers are associated with greater atrophy than expected for age.
Conflict of interest statement
Disclosure: The authors report no conflicts of interest.
Similar articles
-
Inflammatory protein associations with brain MRI measures: Framingham Offspring Cohort.Alzheimers Dement. 2024 Nov;20(11):7465-7478. doi: 10.1002/alz.14147. Epub 2024 Sep 16. Alzheimers Dement. 2024. PMID: 39282876 Free PMC article.
-
Circulating inflammatory biomarkers are related to cerebrovascular disease in older adults.Neurol Neuroimmunol Neuroinflamm. 2018 Nov 14;6(1):e521. doi: 10.1212/NXI.0000000000000521. eCollection 2019 Jan. Neurol Neuroimmunol Neuroinflamm. 2018. PMID: 30568999 Free PMC article.
-
Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: Framingham Heart Study.Neurology. 2015 Feb 24;84(8):825-32. doi: 10.1212/WNL.0000000000001279. Epub 2015 Jan 28. Neurology. 2015. PMID: 25632086 Free PMC article.
-
Inflammatory biomarkers and cerebral small vessel disease: a community-based cohort study.Stroke Vasc Neurol. 2022 Aug;7(4):302-309. doi: 10.1136/svn-2021-001102. Epub 2022 Mar 8. Stroke Vasc Neurol. 2022. PMID: 35260438 Free PMC article.
-
Is there an association between peripheral immune markers and structural/functional neuroimaging findings?Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:295-303. doi: 10.1016/j.pnpbp.2012.12.013. Epub 2013 Jan 11. Prog Neuropsychopharmacol Biol Psychiatry. 2014. PMID: 23313563 Review.
Cited by
-
Three-dimensional facial-image analysis to predict heterogeneity of the human ageing rate and the impact of lifestyle.Nat Metab. 2020 Sep;2(9):946-957. doi: 10.1038/s42255-020-00270-x. Epub 2020 Sep 7. Nat Metab. 2020. PMID: 32895578
-
Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander?Alzheimers Res Ther. 2010 Apr 12;2(2):6. doi: 10.1186/alzrt29. Alzheimers Res Ther. 2010. PMID: 20388190 Free PMC article.
-
Cardiac index is associated with brain aging: the Framingham Heart Study.Circulation. 2010 Aug 17;122(7):690-7. doi: 10.1161/CIRCULATIONAHA.109.905091. Epub 2010 Aug 2. Circulation. 2010. PMID: 20679552 Free PMC article.
-
Early Brain Volume Changes After Stroke: Subgroup Analysis From the AXIS-2 Trial.Front Neurol. 2022 Jan 28;12:747343. doi: 10.3389/fneur.2021.747343. eCollection 2021. Front Neurol. 2022. PMID: 35153972 Free PMC article.
-
Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular disease.J Am Geriatr Soc. 2008 Oct;56(10):1898-903. doi: 10.1111/j.1532-5415.2008.01930.x. Epub 2008 Sep 2. J Am Geriatr Soc. 2008. PMID: 18771451 Free PMC article.
References
-
- Tarkowski E, Rosengren L, Blomstrand C, et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke. 1995;26:1393–1398. - PubMed
-
- Tarkowski E, Tullberg M, Fredman P, Wikkelso C. Correlation between intrathecal sulfatide and TNF-alpha levels in patients with vascular dementia. Dementia Geriatr Cogn Disord. 2003;15:207–211. - PubMed
-
- Yasojima K, Schwab C, McGeer EG, McGeer PL. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer’s disease. Brain Res. 2000;887:80–89. - PubMed
-
- Engelhart MJ, Geerlings MI, Meijer J, et al. Inflammatory proteins in plasma and the risk of dementia: The Rotterdam Study. Arch Neurol. 2004;61:668–672. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01-HC-25195/HC/NHLBI NIH HHS/United States
- R01 NS017950/NS/NINDS NIH HHS/United States
- R01 AG016495/AG/NIA NIH HHS/United States
- HL083102/HL/NHLBI NIH HHS/United States
- K12 HD043444-06/HD/NICHD NIH HHS/United States
- R01 AG008122/AG/NIA NIH HHS/United States
- M01 RR001066/RR/NCRR NIH HHS/United States
- N01HC25195/HL/NHLBI NIH HHS/United States
- AG010129/AG/NIA NIH HHS/United States
- P30 AG013846-06/AG/NIA NIH HHS/United States
- F32 AG022773/AG/NIA NIH HHS/United States
- K23 AG030962-01/AG/NIA NIH HHS/United States
- HD043444/HD/NICHD NIH HHS/United States
- P30 AG013846/AG/NIA NIH HHS/United States
- K12 HD043444/HD/NICHD NIH HHS/United States
- R01 HL076784/HL/NHLBI NIH HHS/United States
- K23 HL083102/HL/NHLBI NIH HHS/United States
- AG022773/AG/NIA NIH HHS/United States
- AG028321/AG/NIA NIH HHS/United States
- AG08122/AG/NIA NIH HHS/United States
- N01HV28178/HV/NHLBI NIH HHS/United States
- K24 HL004334/HL/NHLBI NIH HHS/United States
- R01 HL077447/HL/NHLBI NIH HHS/United States
- K23 AG030962-02/AG/NIA NIH HHS/United States
- K23 AG030962-03/AG/NIA NIH HHS/United States
- K23 AG030962/AG/NIA NIH HHS/United States
- R01 HL067266/HL/NHLBI NIH HHS/United States
- R01 HL067288/HL/NHLBI NIH HHS/United States
- AG021028/AG/NIA NIH HHS/United States
- HL064753/HL/NHLBI NIH HHS/United States
- P01 HL081587/HL/NHLBI NIH HHS/United States
- HL076784/HL/NHLBI NIH HHS/United States
- R01 AG021028/AG/NIA NIH HHS/United States
- AG16495/AG/NIA NIH HHS/United States
- NS017950/NS/NINDS NIH HHS/United States
- R01 AG027081/AG/NIA NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
- M01-RR-01066/RR/NCRR NIH HHS/United States
- R01 AG028321/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials